Mechanisms regulating adipocyte expression of resistin

Autor: Keala X. Tyler, Xiao Hu, Chiraj K. Dalal, Mitchell A. Lazar, Helen B. Hartman
Rok vydání: 2002
Předmět:
Time Factors
endocrine system diseases
Transcription
Genetic

Peroxisome proliferator-activated receptor
Ligands
Biochemistry
Histones
chemistry.chemical_compound
Mice
Adipocyte
Nerve Growth Factor
Adipocytes
Resistin
Promoter Regions
Genetic

chemistry.chemical_classification
Regulation of gene expression
Nuclear Proteins
CREB-Binding Protein
Chromatin
Cell biology
Adipogenesis
Intercellular Signaling Peptides and Proteins
hormones
hormone substitutes
and hormone antagonists

Protein Binding
medicine.medical_specialty
Genetic Vectors
Molecular Sequence Data
Down-Regulation
Biology
Transfection
Cell Line
Rosiglitazone
Fibrinolytic Agents
Internal medicine
medicine
CCAAT-Enhancer-Binding Protein-alpha
Animals
Humans
Molecular Biology
Transcription factor
Binding Sites
Base Sequence
Dose-Response Relationship
Drug

nutritional and metabolic diseases
Proteins
Cell Biology
Blotting
Northern

Precipitin Tests
Introns
Kinetics
Thiazoles
Endocrinology
chemistry
Gene Expression Regulation
Hormones
Ectopic

Trans-Activators
Ectopic expression
Thiazolidinediones
Chromatin immunoprecipitation
E1A-Associated p300 Protein
Zdroj: The Journal of biological chemistry. 277(22)
ISSN: 0021-9258
Popis: Resistin, also known as Adipocyte Secreted Factor (ADSF) and Found in Inflammatory Zone 3 (FIZZ3), is a mouse protein with potential roles in insulin resistance and adipocyte differentiation. The resistin gene is expressed almost exclusively in adipocytes. Here we show that a proximal 264-base pair fragment of the mouse resistin promoter is sufficient for expression in adipocytes. Ectopic expression of the adipogenic transcription factor CCAAT/enhancer-binding protein (C/EBPalpha) was sufficient for expression in non-adipogenic cells. C/EBPalpha binds specifically to a site that is essential for expression of the resistin promoter. Chromatin immunoprecipitation studies of the endogenous gene demonstrated adipocyte-specific association of C/EBPalpha with the proximal resistin promoter in adipocytes but not preadipocytes. C/EBPalpha binding was associated with the recruitment of coactivators p300 and CREB-binding protein and a dramatic increase in histone acetylation in the vicinity of the resistin promoter. The antidiabetic thiazolidinedione (TZD) drug rosiglitazone reduced resistin expression with an ED(50) similar to its K(d) for binding to peroxisome proliferator activated receptor gamma (PPARgamma). Other TZD- and non-TZD PPARgamma ligands also down-regulated resistin expression. However, no functional PPARgamma binding site was found within 6.2 kb of the transcriptional start site, suggesting that if PPARgamma is involved, it is either acting at a long distance from the start site, in an intron, or indirectly. Nevertheless, rosiglitazone treatment selectively decreased histone acetylation at the resistin promoter without a change in occupation by C/EBPalpha, CREB-binding protein, or p300. Thus, adipocyte specificity of resistin gene expression is because of C/EBPalpha binding, leading to the recruitment of transcriptional coactivators and histone acetylation that is characteristic of an active chromatin environment. TZD reduces resistin gene expression at least in part by reducing histone acetylation associated with the binding of C/EBPalpha in mature adipocytes.
Databáze: OpenAIRE